National and Kapodistrian University of Athens
Συστηματικό σκληρόδερμα και προσβολή του οισοφάγου: μελέτη με τη χρησιμοποίηση της μανομετρίας υψηλής ανάλυσης
Abstract
dc:descriptionSystemic sclerosis (SSc) is a chronic autoimmune fibrotic disease affecting the skin and other organs including the gastrointestinal tract. Esophagus is commonly affected in SSc and esophageal function is compromised in up to 90% of patients. Severe esophageal disease in patients with systemic sclerosis (SSc), referred as scleroderma esophagus, is characterised by ineffective or absent peristalsis along with hypotensive esophagogastric junction (hEGJ). The associations between scleroderma oesophagus and different clinical and laboratory manifestations of SSc is still controversial. Our study in fifty-four SSc patients with esophageal symptoms using high resolution manometry (HRM) and comparing the results of HRM parameters with clinical and other manifestations of the disease, showed that scleroderma esophagus was present in less than 2/3 of symptomatic patients with SSc and associated only with esophageal dilation in computed tomography. Esophageal dilation on chest CT may be a non-invasive alternative for evaluation of SSc patients with esophageal symptoms.Esophageal involvement in systemic sclerosis carries significant morbidity and is empirically managed with domperidone, albeit with questionable efficacy. The oral 5-HT1A receptor agonist buspirone may enhance esophageal peristalsis and lower esophageal sphincter (LES) function in healthy volunteers. The acute administration of buspirone in twenty SSc patients, as it was studied using HRM, showed really positive results as it increased the resting pressure of the LES, suggesting an important role of that drug in this specific group of patients. Furthermore, the longterm administration of buspirone, as it was studied in twenty two symptomatic SSc patients using HRM, showed its positive effects both in increasing the resting pressure of the LES and secondly in improving the gastroesophageal reflux disease symptoms, suggesting that buspirone could potentially be given under observation for objective improvement in all patients with SSc who report reflux symptoms despite undergoing standard treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Denaxas, Konstantinos
- Δεναξάς, Κωνσταντίνος
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43323